NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.10% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.90%, a 13.33% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-03-31 was 4.50%, a 4.65% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 4.30%, a 22.86% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 3.50%, a 84.21% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.30%, a 19.44% increase from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.60%, a 56.52% increase from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.30%, a 130.00% increase from fiscal 2021.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 1.00%, a 0.00% change from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 3.10% 10-Q · filed 2026-08-04 | ||||
| 2026-03-31 | 3.90% 10-Q · filed 2026-05-06 | ||||
| 2025-09-30 | 4.50% 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | 4.50% 10-Q · filed 2025-08-06 | ||||
| 2025-03-31 | 4.50% 10-Q · filed 2025-05-07 | ||||
| 2024-12-31 | 4.30% 10-K · filed 2025-03-04 | ||||
| 2024-09-30 | 4.30% 10-Q · filed 2024-10-31 | ||||
| 2024-06-30 | 4.40% 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | 4.30% 10-Q · filed 2024-05-08 | ||||
| 2023-12-31 | 3.60% 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | 3.60% 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | 3.60% 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | 3.50% 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | 2.30% 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | 2.50% 10-Q · filed 2022-11-02 | ||||
| 2022-06-30 | 2.00% 10-Q · filed 2022-08-10 | ||||
| 2022-03-31 | 1.90% 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | 1.00% 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | 1.00% 10-Q · filed 2021-11-03 | ||||
| 2021-06-30 | 1.00% 10-Q · filed 2021-08-03 | ||||
| 2021-03-31 | 1.00% 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | 1.00% 10-K · filed 2022-03-14 | ||||
| 2020-09-30 | 100.00% 10-Q · filed 2020-11-04 | ||||
| 2020-06-30 | 100.00% 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | 1.00% 10-Q · filed 2020-05-18 | ||||
| 2019-12-31 | 2.00% 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 2.00% 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | 3.00% 10-Q · filed 2019-05-09 | ||||
| 2018-12-31 | 3.00% 10-K · filed 2020-03-10 | ||||
| 2018-03-31 | 2.00% 10-Q · filed 2018-05-10 | ||||
| 2017-09-30 | 2.11% 10-Q · filed 2017-11-09 | ||||
| 2017-07-01 | 2.13% 10-Q · filed 2017-08-10 | ||||
| 2017-04-01 | 2.20% 10-Q · filed 2017-05-11 | ||||
| 2016-10-01 | 1.33% 10-Q · filed 2016-11-10 | ||||
| 2016-07-02 | 1.50% 10-Q · filed 2016-08-11 | ||||
| 2016-03-11 | 1.16% 10-Q · filed 2016-11-10 | ||||
| 2015-10-03 | 1.71% 10-Q · filed 2015-11-12 | ||||
| 2015-07-04 | 1.72% 10-Q · filed 2015-08-13 | ||||
| 2015-04-04 | 1.68% 10-Q · filed 2015-05-14 | ||||
| 2014-09-27 | 1.86% 10-Q · filed 2014-11-06 | ||||
| 2014-06-28 | 1.85% 10-Q · filed 2014-08-12 | ||||
| 2014-03-29 | 1.75% 10-Q · filed 2014-05-08 | ||||
| 2012-12-29 | 0.96% 10-K · filed 2013-03-29 | ||||
| 2011-12-31 | 2.20% 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |